📝 Good Documentation Practices (GDP) in Pharmaceutical Quality Systems

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define Good Documentation Practices (GDP) for all personnel working within pharmaceutical manufacturing, laboratory, and quality systems. Adhering to GDP ensures that all data generated, recorded, and stored is reliable, traceable, complete, and compliant with Good Manufacturing Practices (GMP) and global data integrity requirements. This SOP emphasizes adherence to ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available) to maintain the integrity of both paper and electronic records.

2. Scope

This SOP applies to all documentation generated under GMP conditions, including but not limited to:

Batch manufacturing and control records
Laboratory notebooks, logbooks, and analytical reports
Validation protocols, reports, and records
Electronic records, data exports, and instrument printouts
Deviation, change control, and CAPA documentation
Training, audit, and quality assurance records

All personnel responsible for generating, reviewing, approving, or archiving GMP documentation must follow the principles outlined in this SOP to ensure data integrity and regulatory compliance.

3. Responsibilities

Role	Responsibility
All Employees	Generate accurate, legible, and contemporaneous documentation; follow GDP and ALCOA+ principles at all times.
Supervisors	Review documentation for completeness, accuracy, and adherence to GDP before approval or further processing.
Quality Assurance	Approve records, audit adherence to GDP, investigate deviations, and ensure regulatory compliance for data integrity.

4. ALCOA+ Principles and Detailed Guidance

ALCOA+ principles form the foundation of data integrity in pharmaceutical operations. Each principle ensures that records are reliable, reproducible, and compliant with GMP, FDA, and MHRA expectations.

4.1 Attributable

Definition: Each data entry must clearly indicate who performed the activity and when.

Correct (Manual): Operator writes measured value, signs initials, and records date/time immediately.
Incorrect (Manual): Data entered by someone else later, or unsigned entries.
Correct (Electronic): Data saved under a unique user ID with automatic timestamp.
Incorrect (Electronic): Shared login IDs used by multiple analysts.

4.2 Legible

Definition: Data must be readable and understandable for the entire retention period.

Correct (Manual): Clear handwriting using blue or black permanent ink.
Incorrect (Manual): Scribbled, faded, or overwritten entries.
Correct (Electronic): Clearly labeled reports and filenames with no ambiguous symbols.

4.3 Contemporaneous

Definition: Data must be recorded at the time the activity is performed.

Correct (Manual): Recording temperature immediately after measurement.
Incorrect (Manual): Writing all values at the end of the shift from memory.
Correct (Electronic): Instrument automatically timestamps results.

4.4 Original

Definition: Data should be the first capture or a verified true copy.

Correct: Original chromatogram printout attached to the analytical report.
Correct (Certified Copy): True copy signed and dated by QA.
Incorrect: Transcribing results from loose paper into a notebook later.

4.5 Accurate

Definition: Data must be correct, truthful, and free from manipulation.

Correct: Calculations verified by a second person before approval.
Incorrect: Adjusting values to meet specification limits without justification.
Electronic Correct: System-calculated results recorded automatically.

4.6 Complete

Definition: All data, including failed results, repeats, and deviations, must be recorded.

Correct: Recording all trial injections, including failures.
Incorrect: Omitting failed or out-of-specification results.
Batch Record Example: All processing steps completed with no blank fields.

4.7 Consistent

Definition: Data must follow logical sequence and time order.

Correct: Process steps recorded chronologically.
Incorrect: Back-dated or out-of-sequence time entries.
Electronic: Audit trail reflects logical workflow and sequence.

4.8 Enduring

Definition: Data must be recorded on durable, permanent media.

Correct (Manual): Use permanent ink; paper records preserved properly.
Incorrect: Pencil, erasable ink, sticky notes.
Electronic: Secure, validated systems with backup and disaster recovery.

4.9 Available

Definition: Data must be readily retrievable for review, inspection, or audit.

Correct: Archived records indexed and retrievable within defined timelines.
Incorrect: Misplaced or missing records.
Electronic: Controlled access systems with search functionality.

5. Documentation Rules & Corrections

Use only indelible ink (blue or black).
Record data immediately after performing the activity.
Do not leave blank fields; mark “N/A” if not applicable, with initials and date.
Each entry must include date and initials/signature.
Correction fluid and overwriting are prohibited. Corrections must be struck through with a single line, and the correct value, initials, date, and reason must be added.
Example: Entered: Weight = 45.0 g → Correct: 45.5 g → Strike 45.0, write 45.5, Initials / Date / “Balance reading error”

6. Electronic Records

All electronic systems must be validated with audit trails enabled.
Each user must have a unique login ID and password; sharing is prohibited.
Electronic timestamps must be enabled to reflect the actual time of activity.
Electronic reports must reflect original, unmodified data; no manual overwrites allowed.
Electronic records must be backed up according to SOP and disaster recovery procedures.

7. Training & Compliance

All personnel must be trained on GDP and ALCOA+ principles during induction and periodically thereafter.
Training records must be documented and retained for review.
Non-compliance must be addressed through deviation reports, corrective and preventive actions (CAPA), and retraining.
Periodic internal audits shall be conducted to monitor GDP compliance across departments.

8. Regulatory References

EU GMP Chapter 4 – Documentation Requirements
FDA 21 CFR 211.180 – Records & Documentation
WHO GMP Documentation Guidelines
MHRA Data Integrity Guidance
ICH Q7, Q9 – Quality Guidelines
USP <1058> Analytical Instrument Qualification (for data capture)

9. FDA & MHRA Data Integrity Observations

Regulatory inspections often identify GDP deficiencies that can lead to Form 483 observations, Warning Letters, or MHRA enforcement actions. This section summarizes common findings and correct practices according to ALCOA+.

9.1 Attributable

Issue: Batch records without operator initials or dates.

Correct Practice: Each entry must be signed or electronically linked to a unique user ID with timestamp.

9.2 Legible

Issue: Illegible or overwritten critical data.

Correct Practice: Maintain clear, readable entries in permanent ink; electronic systems must be clearly labeled.

9.3 Contemporaneous

Issue: Data recorded retrospectively from memory.

Correct Practice: Record data at the time of activity; electronic instruments should automatically timestamp readings.

9.4 Original

Issue: Originals discarded after transcription or selective printouts only.

Correct Practice: Retain original records or certified true copies, including failed results.

9.5 Accurate

Issue: Manual or electronic data altered to meet specifications without documentation.

Correct Practice: Ensure calculations are verified; data must reflect true results.

9.6 Complete

Issue: Omitting failed runs, deviations, or repeats.

Correct Practice: Record all data comprehensively, including failures and exceptions.

9.7 Consistent

Issue: Out-of-sequence or back-dated entries.

Correct Practice: Chronological entries with audit trails reflecting logical workflow.

9.8 Enduring

Issue: Loose notes, sticky notes, or electronic data on unvalidated drives.

Correct Practice: Use durable media or validated electronic systems with backups.

9.9 Available

Issue: Batch records not retrievable or electronic data inaccessible.

Correct Practice: Maintain properly indexed and readily accessible records for audit and inspection.

Search This Blog

SOPNest – Your Home for Pharma SOPs